Physician profile
Phyllis C Everett
NPI 1861472458
$2,868.70
in general payments reported to CMS, 2019-2025
20 companies · $838 in 2025
The $838 reported for 2025 was more than what 82% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $280 · 2022: $662 · 2023: $581 · 2024: $509 · 2025: $838.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,927.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,927.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $456.95 | 2021-2025 | |
| Amgen INC. | $333.87 | 2024-2025 | Otezla, Evenity |
| Abbott Laboratories | $295.12 | 2022-2023 | Freestyle Libre 3 |
| Novo Nordisk INC | $287.20 | 2021-2022 | |
| Astrazeneca Pharmaceuticals Lp | $215.49 | 2023-2024 | Airsupra, Farxiga |
| Dexcom, INC. | $198.41 | 2024-2025 | Dexcom G6 Transmitter |
| Alexion Pharmaceuticals, INC. | $130.50 | 2021-2025 | Strensiq |
| Lundbeck LLC | $121.48 | 2025 | Vyepti |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $111.12 | 2025 | Caplyta |
| Neurocrine Biosciences, INC. | $106.44 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $99.14 | 2021 | |
| Sk Life Science, INC. | $88.40 | 2023 | Xcopri |
| Argenx US, INC. | $87.73 | 2025 | Vyvgart |
| Otsuka America Pharmaceutical, INC. | $85.53 | 2023 | Jynarque |
| Biogen, INC. | $70.94 | 2023 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $64.84 | 2024 | Auvelity |
| Janssen Pharmaceuticals, INC | $37.50 | 2022 | |
| Pfizer INC. | $36.49 | 2023 | |
| Antares Pharma, INC. | $29.36 | 2025 | Xyosted |
| Biodelivery Sciences International, INC. | $12.19 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Phyllis Everett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.